Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 983

1.

Think First, Cut Last - Lessons from a Clinical Trial of Refractory Heartburn.

Talley NJ.

N Engl J Med. 2019 Oct 17;381(16):1580-1582. doi: 10.1056/NEJMe1911623. No abstract available.

PMID:
31618545
2.

No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.

Hugerth LW, Andreasson A, Talley NJ, Forsberg AM, Kjellström L, Schmidt PT, Agreus L, Engstrand L.

Gut. 2019 Oct 10. pii: gutjnl-2019-318717. doi: 10.1136/gutjnl-2019-318717. [Epub ahead of print]

3.

Tangible pathologies in functional dyspepsia.

Walker MM, Potter MD, Talley NJ.

Best Pract Res Clin Gastroenterol. 2019 Jun - Aug;40-41:101650. doi: 10.1016/j.bpg.2019.101650. Epub 2019 Aug 16. Review.

PMID:
31594648
4.

Zonulin in serum as a biomarker fails to identify the IBS, functional dyspepsia and non-coeliac wheat sensitivity.

Talley NJ, Holtmann GJ, Jones M, Koloski NA, Walker MM, Burns G, Potter MDE, Shah A, Keely S.

Gut. 2019 Sep 28. pii: gutjnl-2019-318664. doi: 10.1136/gutjnl-2019-318664. [Epub ahead of print] No abstract available.

PMID:
31563879
5.

Z-line alterations and gastroesophageal reflux: an endoscopic population-based prospective cohort study.

Wallner B, Björ O, Andreasson A, Vieth M, Schmidt PT, Hellström PM, Forsberg A, Talley NJ, Agreus L.

Scand J Gastroenterol. 2019 Sep;54(9):1065-1069. doi: 10.1080/00365521.2019.1656775. Epub 2019 Aug 27.

PMID:
31453726
6.

Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol.

Basnayake C, Kamm MA, Salzberg M, Khera A, Liew D, Burrell K, Wilson-O'Brien A, Stanley A, Talley NJ, Thompson AJ.

Contemp Clin Trials. 2019 Sep;84:105828. doi: 10.1016/j.cct.2019.105828. Epub 2019 Aug 19.

PMID:
31437539
7.

Emerging evidence that irritable bowel syndrome & functional dyspepsia are microbial diseases.

Talley NJ, Walker MM.

Indian J Med Res. 2019 Apr;149(4):437-440. doi: 10.4103/ijmr.IJMR_84_19. No abstract available.

8.

Isolates from Colonic Spirochetosis in Humans Show High Genomic Divergence and Potential Pathogenic Features but Are Not Detected Using Standard Primers for the Human Microbiota.

Thorell K, Inganäs L, Backhans A, Agréus L, Öst Å, Walker MM, Talley NJ, Kjellström L, Andreasson A, Engstrand L.

J Bacteriol. 2019 Oct 4;201(21). pii: e00272-19. doi: 10.1128/JB.00272-19. Print 2019 Nov 1.

9.

Oesophageal food bolus obstruction and eosinophilic oesophagitis.

Cook D, Zala A, Bollipo S, Potter MDE, Walker MM, Talley NJ.

Intern Med J. 2019 Aug;49(8):1032-1034. doi: 10.1111/imj.14389.

PMID:
31387146
10.

Editorial: the overlap between dyspepsia and gastro-oesophageal reflux-is duodenal eosinophilia the missing link? Authors' reply.

Ronkainen J, Aro P, Walker MM, Agréus L, Johansson SE, Jones M, Talley NJ.

Aliment Pharmacol Ther. 2019 Aug;50(4):455-456. doi: 10.1111/apt.15406. No abstract available.

PMID:
31359481
11.

Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.

Talley NJ, Holtmann G, Walker MM, Burns G, Potter M, Shah A, Jones M, Koloski NA, Keely S.

Clin Transl Gastroenterol. 2019 Jul;10(7):e00064. doi: 10.14309/ctg.0000000000000064.

12.

The Gut Microbiota in Collagenous Colitis Shares Characteristics With Inflammatory Bowel Disease-Associated Dysbiosis.

Carstens A, Dicksved J, Nelson R, Lindqvist M, Andreasson A, Bohr J, Tysk C, Talley NJ, Agréus L, Engstrand L, Halfvarson J.

Clin Transl Gastroenterol. 2019 Jul;10(7):e00065. doi: 10.14309/ctg.0000000000000065.

13.

Effects of Psychology and Extragastrointestinal Symptoms on Health Care Use by Subjects With and Without Irritable Bowel Syndrome.

McNaughton DT, Andreasson A, Ljótsson B, Beath AP, Hush JM, Talley NJ, Ljunggren G, Schmidt PT, Agréus L, Jones MP.

Clin Gastroenterol Hepatol. 2019 Jul 16. pii: S1542-3565(19)30752-9. doi: 10.1016/j.cgh.2019.07.019. [Epub ahead of print]

PMID:
31323378
14.

Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Shah A, Crawford D, Burger D, Martin N, Walker M, Talley NJ, Tallis C, Jones M, Stuart K, Keely S, Lewindon P, Macdonald GA, Morrison M, Holtmann GJ.

Semin Liver Dis. 2019 Nov;39(4):432-441. doi: 10.1055/s-0039-1688501. Epub 2019 Jul 17.

PMID:
31315136
15.

Response to Tursi.

Jarbrink-Sehgal ME, Rassam L, Jasim A, Walker M, Talley NJ, Agreus L, Andreasson A, Thelin Schmidt P.

Am J Gastroenterol. 2019 Aug;114(8):1350-1351. doi: 10.14309/ajg.0000000000000319. No abstract available.

PMID:
31313712
16.

Response to Zidar et al.

Jarbrink-Sehgal ME, Rassam L, Jasim A, Walker M, Talley NJ, Agréus L, Andreasson A, Schmidt PT.

Am J Gastroenterol. 2019 Aug;114(8):1348-1349. doi: 10.14309/ajg.0000000000000323. No abstract available.

PMID:
31313709
17.

Potential roles of Helicobacter pylori treatment, body mass index and waist circumference in the causation of erosive esophagitis: a randomized clinical trial (HEROES-GERD).

Mazzoleni F, Mazzoleni LE, de Magalhães Francesconi CF, Sander GB, Von Reisswitz PS, Milbradt TC, da Veiga Chaves Picon R, Uchoa DM, De Bona LR, Andreolla HF, Breyer HP, Spinato Torresini R, Ott EA, Wortmann AC, de Lucena Theil A, Stifft J, Zenker RP, Krumel CF, Michalczuk MT, De Araujo A, Canevese AP, Volpato N, da Silva CA, Schaefer PG, Titton NF, Longo L, Edelweiss MI, Simon D, Talley NJ.

Int J Obes (Lond). 2019 Jun 13. doi: 10.1038/s41366-019-0391-3. [Epub ahead of print]

PMID:
31197249
18.

Duodenal eosinophilia is associated with functional dyspepsia and new onset gastro-oesophageal reflux disease.

Ronkainen J, Aro P, Walker MM, Agréus L, Johansson SE, Jones M, Talley NJ.

Aliment Pharmacol Ther. 2019 Jul;50(1):24-32. doi: 10.1111/apt.15308. Epub 2019 May 20.

PMID:
31107579
19.

Dual histamine blockade for the treatment of adult functional dyspepsia: a single centre experience.

Potter MDE, Goodsall TM, Walker MM, Talley NJ.

Gut. 2019 Apr 30. pii: gutjnl-2019-318412. doi: 10.1136/gutjnl-2019-318412. [Epub ahead of print] No abstract available.

PMID:
31040169
20.

Cannabinoid use in practice in Australasia-Better guidance and new drug information systems will be essential for prescribers.

Martin JH, Talley NJ.

Br J Clin Pharmacol. 2019 Aug;85(8):1664-1665. doi: 10.1111/bcp.13963. Epub 2019 May 23. No abstract available.

PMID:
30980683
21.

Follow up on atopy and the gastrointestinal tract - a review of a common association 2018.

Walker MM, Talley NJ, Keely S.

Expert Rev Gastroenterol Hepatol. 2019 May;13(5):437-445. doi: 10.1080/17474124.2019.1596025. Epub 2019 Mar 27.

PMID:
30900475
22.

In the ZOne: How Impedance Facilitates Progress in Functional Dyspepsia Research.

Keely S, Talley NJ.

Dig Dis Sci. 2019 Mar 18. doi: 10.1007/s10620-019-05575-w. [Epub ahead of print] No abstract available.

PMID:
30887149
23.

Diverticulosis, Symptoms and Colonic Inflammation: A Population-Based Colonoscopy Study.

Järbrink-Sehgal ME, Rassam L, Jasim A, Walker MM, Talley NJ, Agréus L, Andreasson A, Schmidt PT.

Am J Gastroenterol. 2019 Mar;114(3):500-510. doi: 10.14309/ajg.0000000000000113.

PMID:
30839393
24.

Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review.

B Biomed GB, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S.

Am J Gastroenterol. 2019 Mar;114(3):429-436. doi: 10.1038/s41395-018-0377-0.

PMID:
30839392
25.

Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease.

Shah A, Morrison M, Burger D, Martin N, Rich J, Jones M, Koloski N, Walker MM, Talley NJ, Holtmann GJ.

Aliment Pharmacol Ther. 2019 Mar;49(6):624-635. doi: 10.1111/apt.15133. Epub 2019 Feb 8. Review.

PMID:
30735254
26.

Risk factors for upper and lower functional gastrointestinal disorders in Persian Gulf War Veterans during and post-deployment.

Tuteja AK, Talley NJ, Stoddard GJ, Samore MH, Verne GN.

Neurogastroenterol Motil. 2019 Mar;31(3):e13533. doi: 10.1111/nmo.13533. Epub 2019 Jan 29.

PMID:
30697884
27.

Population based study: atopy and autoimmune diseases are associated with functional dyspepsia and irritable bowel syndrome, independent of psychological distress.

Koloski N, Jones M, Walker MM, Veysey M, Zala A, Keely S, Holtmann G, Talley NJ.

Aliment Pharmacol Ther. 2019 Mar;49(5):546-555. doi: 10.1111/apt.15120. Epub 2019 Jan 27.

PMID:
30687959
28.

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome.

Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ.

Aliment Pharmacol Ther. 2019 Feb;49(4):389-397. doi: 10.1111/apt.15077. Epub 2019 Jan 20.

PMID:
30663077
29.

Baseline Impedance Measured During High-resolution Esophageal Impedance Manometry in Patients With Rumination Syndrome is as Abnormal as in Patients With GERD.

Halland M, Ravi K, Nelson HA, Katzka DA, Talley NJ, Crowell MD.

J Clin Gastroenterol. 2018 Dec 19. doi: 10.1097/MCG.0000000000001159. [Epub ahead of print]

PMID:
30575633
30.

Duodenal and Rectal Eosinophilia Are New Biomarkers of Nonceliac Gluten Sensitivity.

Järbrink-Sehgal ME, Talley NJ.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):613-615. doi: 10.1016/j.cgh.2018.11.039. Epub 2018 Nov 28. No abstract available.

PMID:
30502506
31.

Australian health professionals' statement on climate change and health.

Arabena K, Armstrong F, Berry H, Brooks P, Capon T, Crabb B, Demaio A, Doherty P, Lewin S, Lo S, Lopez A, McMichael C, McPake B, Moodie R, Nolan T, Ruff T, Sainsbury P, Selvey L, Shearman D, Stanley F, Talley NJ, Watts N.

Lancet. 2018 Nov 17;392(10160):2169-2170. doi: 10.1016/S0140-6736(18)32610-2. Epub 2018 Oct 24. No abstract available.

PMID:
30497656
32.

Eosinophilic colitis and colonic eosinophilia.

Walker MM, Potter MD, Talley NJ.

Curr Opin Gastroenterol. 2019 Jan;35(1):42-50. doi: 10.1097/MOG.0000000000000492.

PMID:
30480590
33.

Duodenal Pathology in Patients with Rumination Syndrome: Duodenal Eosinophilia and Increased Intraepithelial Lymphocytes.

Halland M, Talley NJ, Jones M, Murray JA, Cameron R, Walker MM.

Dig Dis Sci. 2019 Mar;64(3):832-837. doi: 10.1007/s10620-018-5387-7. Epub 2018 Nov 26.

PMID:
30478768
34.

The Nepean Dyspepsia Index is a valid instrument for measuring quality-of-life in functional dyspepsia.

Jones MP, Sato YA, Talley NJ.

Eur J Gastroenterol Hepatol. 2019 Mar;31(3):329-333. doi: 10.1097/MEG.0000000000001314.

PMID:
30461521
35.

Epidemiology and Pathophysiology of Gastroparesis.

Moshiree B, Potter M, Talley NJ.

Gastrointest Endosc Clin N Am. 2019 Jan;29(1):1-14. doi: 10.1016/j.giec.2018.08.010. Review.

PMID:
30396519
36.

Gastrointestinal recall questionnaires compare poorly with prospective patient diaries for gastrointestinal symptoms: data from population and primary health centre samples.

Jones MP, Walter S, Faresjö Å, Grodzinsky E, Kjellström L, Viktorsson L, Talley NJ, Agreus L, Andreasson A.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):163-169. doi: 10.1097/MEG.0000000000001296.

PMID:
30394943
37.

Development of a real-time patient-reported outcome measure for symptom assessment in patients with functional dyspepsia using the experience sampling method.

Smeets FGM, Keszthelyi D, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Conchillo JM, Kruimel JW, Van Os J, Masclee AAM.

Neurogastroenterol Motil. 2019 Feb;31(2):e13496. doi: 10.1111/nmo.13496. Epub 2018 Nov 4.

PMID:
30393939
38.

Letter: gluten sensitivity in patients with inflammatory bowel disease.

Potter MD, Walker MM, Jones MP, Koloski NA, Keely S, Talley NJ.

Aliment Pharmacol Ther. 2018 Nov;48(10):1167-1168. doi: 10.1111/apt.15012. No abstract available.

PMID:
30375691
39.

Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.

Tuteja AK, Talley NJ, Stoddard GJ, Verne GN.

Dig Dis Sci. 2019 Mar;64(3):838-845. doi: 10.1007/s10620-018-5344-5. Epub 2018 Oct 28.

PMID:
30370492
40.

Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.

von Wulffen M, Talley NJ, Hammer J, McMaster J, Rich G, Shah A, Koloski N, Kendall BJ, Jones M, Holtmann G.

Dig Dis Sci. 2019 Feb;64(2):480-486. doi: 10.1007/s10620-018-5343-6. Epub 2018 Oct 27.

PMID:
30368683
41.

Progress towards a sustainable clinical academic training pathway.

Windsor J, Garrod T, Tan L, Talley NJ, Churchill J, Farmer E, Smith JA.

ANZ J Surg. 2018 Oct;88(10):952-953. doi: 10.1111/ans.14706. No abstract available.

PMID:
30276997
42.

Influence of cigarette smoking on the human duodenal mucosa-associated microbiota.

Shanahan ER, Shah A, Koloski N, Walker MM, Talley NJ, Morrison M, Holtmann GJ.

Microbiome. 2018 Aug 29;6(1):150. doi: 10.1186/s40168-018-0531-3.

43.

What's in a name? 'Non-coeliac gluten or wheat sensitivity': controversies and mechanisms related to wheat and gluten causing gastrointestinal symptoms or disease.

Potter MDE, Walker MM, Keely S, Talley NJ.

Gut. 2018 Dec;67(12):2073-2077. doi: 10.1136/gutjnl-2018-316360. Epub 2018 Jul 30. Review. No abstract available.

PMID:
30061187
44.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ.

Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6. Review.

45.

Proton pump inhibitors and suppression of duodenal eosinophilia in functional dyspepsia.

Potter MDE, Wood NK, Walker MM, Jones MP, Talley NJ.

Gut. 2019 Jul;68(7):1339-1340. doi: 10.1136/gutjnl-2018-316878. Epub 2018 Jul 7. No abstract available.

PMID:
29982192
46.

A Serological Diagnosis of Coeliac Disease Is Associated with Osteoporosis in Older Australian Adults.

Potter MDE, Walker MM, Hancock S, Holliday E, Brogan G, Jones M, McEvoy M, Boyle M, Talley NJ, Attia J.

Nutrients. 2018 Jun 29;10(7). pii: E849. doi: 10.3390/nu10070849.

47.

Inconsistent symptom clusters for functional gastrointestinal disorders in Asia: is Rome burning?

Holtmann GJ, Talley NJ.

Gut. 2018 Nov;67(11):1911-1915. doi: 10.1136/gutjnl-2017-314775. Epub 2018 Jun 19. No abstract available.

PMID:
29921653
48.

Wheat Intolerance and Chronic Gastrointestinal Symptoms in an Australian Population-based Study: Association Between Wheat Sensitivity, Celiac Disease and Functional Gastrointestinal Disorders.

Potter MDE, Walker MM, Jones MP, Koloski NA, Keely S, Talley NJ.

Am J Gastroenterol. 2018 Jul;113(7):1036-1044. doi: 10.1038/s41395-018-0095-7. Epub 2018 Jun 19.

PMID:
29915405
49.

Comparison of Lactase Variant MCM6 -13910 C>T Testing and Self-report of Dairy Sensitivity in Patients With Irritable Bowel Syndrome.

Almazar AE, Chang JY, Larson JJ, Atkinson EJ, Locke GR, Talley NJ, Saito YA.

J Clin Gastroenterol. 2019 Jul;53(6):e227-e231. doi: 10.1097/MCG.0000000000001065.

PMID:
29912753
50.

The Rise and Rise of Eosinophilic Gut Diseases Including Eosinophilic Esophagitis Is Probably Not Explained by the Disappearance of Helicobacter pylori, so Who or What's to Blame?

Talley NJ, Walker MM.

Am J Gastroenterol. 2018 Jul;113(7):941-944. doi: 10.1038/s41395-018-0125-5. Epub 2018 Jun 18.

PMID:
29910462

Supplemental Content

Loading ...
Support Center